A market review on Follicular lymphoma treatment requirements and consumer demands
- The global follicular lymphoma treatment market is segmented on the basis of treatment type, route of administration, end-users and geography
- The global follicular lymphoma treatment market is expected to reach XX USD Mn by 2024 with a growing CAGR of XX% from 2018 to 2024
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
Follicular lymphoma is a type of non-Hodgkin’s lymphoma which attacks B-lymphocytes of human body severely. Follicular lymphoma is the most common type and indolent type of lymphoma. Follicular lymphoma is diagnosed by biopsy, blood tests, and X-rays among others. Follicular lymphoma can be treated with chemotherapy, radiation therapy, targeted therapy, and stem cell transplant.
The market for follicular lymphoma treatment is booming with factors such as rise in number of cases of follicular lymphoma, family history of blood disorders, increase in R&D activities for the innovation of newer drugs, and technological advancements in disease diagnosis. Moreover, promising pipeline products, innovation of newer therapies such as monoclonal antibodies, and government initiations for the cancer management are expected to boost the market. However, strict regulatory policies for drug approval, the high cost of treatment, and adverse side effects associated with the treatment are expected to hamper the market growth.
The global market of follicular lymphoma treatment is divided into following categories-
- Treatment type
- Alkylating Agents
- Nucleoside Analogues
- Anthracycline Derivatives
- Monoclonal Antibodies
- Stem Cell Transplantation
- Route of administration
Hospitals, retail pharmacies, oncology centers and academic research institutes
And lastly, on the basis of geographical regions, the global market has five major regions- North America, Latin America, Europe, the Middle East & Africa and Asia-Pacific.
North America follicular lymphoma treatment market is growing at notable rate due to increase in the prevalence of follicular lymphoma, increase in R&D activities for the innovation of newer drugs, and an increase in healthcare expenditure in this region.
European market significantly growing due to the adoption of newer therapies, sophisticated healthcare infrastructure, an increase in the prevalence of follicular lymphoma due to change in lifestyle in the region.
While Asia-Pacific follicular lymphoma treatment market has a lucrative growth owing to the large patient pool, increase in awareness about lymphoma treatment, and government initiations for the prevention of cancer are expected to fuel the market in this region.
Some of the key market players are Hoffmann La Roche Ltd. (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline plc (U.K.), Bayer AG (Germany), Epizyme Inc. (U.S.), Bristol Myers Squibb (U.S.), Johnson and Johnson Services Inc. (U.S.) are name to few. In 2017, U.S. FDA approved Bayer AG’s Aliqopa (Copanlisib) for the treatment of follicular lymphoma.
Most of the international players are actively involved in the development of newer products. Moreover, rising adoption of monoclonal antibodies for targeted therapies propels the follicular lymphoma treatment market. Furthermore, acquisitions and mergers, collaborations, product approvals, and product launchings are the strategies followed by the market players for gaining larger revenue share in follicular lymphoma treatment market. For instance, in 2017, Health Canada approved Roche’s Gazyva (Obinutuzumab) for patients with previously treated follicular lymphoma.
Key Questions Answered
- What is the current and future follicular lymphoma treatment market outlook worldwide? What trends are affecting the global market?
- What is the competitive landscape and market share of major players in the follicular lymphoma treatment globally?
- What are the key, high growth markets that follicular lymphoma treatment manufacturers should expand into? Which market segments are growing the fastest?
- What are the unmet needs with the follicular lymphoma treatment currently on the market? How will emerging technologies fulfil these unmet needs?
- What is physician perception and market outlook of follicular lymphoma treatment?
- What are the challenges and barriers that have hindered widespread adoption of follicular lymphoma treatment?
Reasons to buy follicular lymphoma treatment market Report:
- Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
- Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
- Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
- Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
- A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
- Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
- Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.
Contact to Precision Business Insights,
152 – 160 City Road,
London EC1V 2NX
Toll Free (US): +1-866-598-1553